These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Structural Analysis of Variable Domain Glycosylation of Anti-Citrullinated Protein Antibodies in Rheumatoid Arthritis Reveals the Presence of Highly Sialylated Glycans. Hafkenscheid L; Bondt A; Scherer HU; Huizinga TW; Wuhrer M; Toes RE; Rombouts Y Mol Cell Proteomics; 2017 Feb; 16(2):278-287. PubMed ID: 27956708 [TBL] [Abstract][Full Text] [Related]
9. Sialylated immunoglobulin G: a promising diagnostic and therapeutic strategy for autoimmune diseases. Li D; Lou Y; Zhang Y; Liu S; Li J; Tao J Theranostics; 2021; 11(11):5430-5446. PubMed ID: 33859756 [TBL] [Abstract][Full Text] [Related]
10. Preferential recognition of epitopes on AGE-IgG by the autoantibodies in rheumatoid arthritis patients. Ahmad S; Habib S; Moinuddin ; Ali A Hum Immunol; 2013 Jan; 74(1):23-7. PubMed ID: 23073292 [TBL] [Abstract][Full Text] [Related]
11. A new antibody in rheumatoid arthritis targeting glycated IgG: IgM anti-IgG-AGE. Ligier S; Fortin PR; Newkirk MM Br J Rheumatol; 1998 Dec; 37(12):1307-14. PubMed ID: 9973155 [TBL] [Abstract][Full Text] [Related]
12. Autoantibodies and other serological markers in rheumatoid arthritis: predictors of disease activity? da Mota LM; dos Santos Neto LL; de Carvalho JF Clin Rheumatol; 2009 Oct; 28(10):1127-34. PubMed ID: 19597699 [TBL] [Abstract][Full Text] [Related]
13. Advanced glycation endproducts (AGE) on IgG, a target for circulating antibodies in North American Indians with rheumatoid arthritis (RA). Newkirk MM; LePage K; Niwa T; Rubin L Cell Mol Biol (Noisy-le-grand); 1998 Nov; 44(7):1129-38. PubMed ID: 9846895 [TBL] [Abstract][Full Text] [Related]
14. B cell depletion with rituximab in patients with rheumatoid arthritis: Multiplex bead array reveals the kinetics of IgG and IgA antibodies to citrullinated antigens. Cambridge G; Leandro MJ; Lahey LJ; Fairhead T; Robinson WH; Sokolove J J Autoimmun; 2016 Jun; 70():22-30. PubMed ID: 27055777 [TBL] [Abstract][Full Text] [Related]
15. The specificity of human autoantibodies to IgG: the development of methodology for measuring the specificity of antiglobulin isotypes in rheumatoid and normal sera. March RE; Winrow VR; Holborow EJ Rheumatol Int; 1986; 6(4):155-60. PubMed ID: 3097788 [TBL] [Abstract][Full Text] [Related]
16. Extensive glycosylation of ACPA-IgG variable domains modulates binding to citrullinated antigens in rheumatoid arthritis. Rombouts Y; Willemze A; van Beers JJ; Shi J; Kerkman PF; van Toorn L; Janssen GM; Zaldumbide A; Hoeben RC; Pruijn GJ; Deelder AM; Wolbink G; Rispens T; van Veelen PA; Huizinga TW; Wuhrer M; Trouw LA; Scherer HU; Toes RE Ann Rheum Dis; 2016 Mar; 75(3):578-85. PubMed ID: 25587188 [TBL] [Abstract][Full Text] [Related]
17. Glycan profiling of anti-citrullinated protein antibodies isolated from human serum and synovial fluid. Scherer HU; van der Woude D; Ioan-Facsinay A; el Bannoudi H; Trouw LA; Wang J; Häupl T; Burmester GR; Deelder AM; Huizinga TW; Wuhrer M; Toes RE Arthritis Rheum; 2010 Jun; 62(6):1620-9. PubMed ID: 20178128 [TBL] [Abstract][Full Text] [Related]
18. Rheumatoid factors: what's new? Westwood OM; Nelson PN; Hay FC Rheumatology (Oxford); 2006 Apr; 45(4):379-85. PubMed ID: 16418203 [No Abstract] [Full Text] [Related]